Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haloperidol: therapeutic window in schizophrenia

D J Palao1, A Arauxo, M Brunet

  • 1Department of Psychiatry, Hospital Clínic i Provincial, Barcelona, Spain.

Journal of Clinical Psychopharmacology
|October 1, 1994
PubMed
Summary

This study found an optimal therapeutic window for haloperidol plasma levels in schizophrenic patients. Maintaining haloperidol within 5.5 to 14.4 ng/ml improves clinical response and reduces negative symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum: The Hubbard dimer: a density functional case study of a many-body problem (2015<i>J. Phys.: Condens. Matter</i><b>27</b>393001).

Journal of physics. Condensed matter : an Institute of Physics journal·2026
Same author

A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250).

ESMO open·2025
Same author

Resilient outcomes in people with a history of mental disorder during the COVID-19 pandemic: an international 2-years longitudinal prospective study.

Social psychiatry and psychiatric epidemiology·2025
Same author

The role of childhood maltreatment and mental health disorders on suicidal behaviour in adolescents.

Child abuse & neglect·2024
Same author

Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology.

Nature metabolism·2024
Same author

Metabolic and productive adaptive response of beef cows to successive short-nutritional challenges.

Research in veterinary science·2024

Area of Science:

  • Pharmacology
  • Psychiatry
  • Clinical Neuroscience

Background:

  • Haloperidol is a typical antipsychotic used for schizophrenia.
  • Determining optimal therapeutic plasma levels is crucial for effective treatment.
  • Previous research suggests a dose-response relationship, but a defined therapeutic window is needed.

Purpose of the Study:

  • To investigate the relationship between haloperidol plasma concentrations and clinical response in schizophrenic patients.
  • To identify a therapeutic window for haloperidol to optimize treatment outcomes.

Main Methods:

  • Twenty-two inpatients with schizophrenia received fixed oral doses of haloperidol (10, 20, or 30 mg) for 3 weeks.
  • Plasma haloperidol levels were measured.
  • Clinical response was assessed using the Brief Psychiatric Rating Scale.

Related Experiment Videos

  • A nonlinear regression model was employed to analyze the data.

    • Main Results:

    • A curvilinear relationship was observed between haloperidol plasma levels and clinical response (pseudo-R2 = 0.85, p < 0.001).
    • Three drug level ranges were identified: low (< 5.5 ng/ml), optimal (5.5–14.4 ng/ml), and high/toxic (> 14.4 ng/ml).
    • Higher haloperidol levels were associated with less improvement or worsening of negative symptoms and a trend towards more extrapyramidal symptoms.

    Conclusions:

    • The study supports the existence of a therapeutic window for haloperidol in schizophrenia treatment.
    • Achieving haloperidol plasma levels within the optimal range (5.5–14.4 ng/ml) increases the probability of global clinical improvement.
    • This finding has significant implications for clinical practice in managing schizophrenia exacerbations.